10.24.12
São Paulo, Brazil

Rubella and CRS Global Advocacy

Rubella, also known as German Measles, is an often mild disease whose symptoms can range from a fever and rash to signs too mild to detect.  When contracted by a pregnant woman in her first 20 weeks, however, rubella can lead to Congenital Rubella Syndrome (CRS) in the fetus, and the effects can be devastating. The disease can cause severe growth and mental retardation, deafness and other developmental problems when the fetus becomes infected. Though the burden of CRS is not well documented, the WHO estimates that in developing countries alone 100,000 cases of CRS occur each year.

One year ago at the GAVI Alliance pledge conference, partners exceeded expectations by pledging $4.3 billion dollars.

Dr. de Quadros and Hotez featured in Vaccine special supplement!

Progress Toward Rubella Elimination and CRS Prevention in Europe Proceedings

Progress Toward Rubella Elimination and CRS prevention in Europe was held 8-10 February, 2012 in Rome, Italy. Over 150 people from 47 countries came together to review the latest developments in the fight against rubella and CRS in Europe. A special session on measles was also convened to review the numerous overlaps in these two areas. Proceedings are now available for download above.

Late last week, the GAVI Alliance board announced its plan to fund the introduction of vaccine

Pages

Subscribe to RSS - Rubella